Media Alert: Atossa Genetics to Sponsor Screenings of

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Media Alert: Atossa Genetics to Sponsor Screenings of Decoding Annie Parker at the Seattle International Film Festival on June 6 and 8, 2013

SEATTLE, WA--(Marketwired - May 29, 2013) - Atossa Genetics, Inc.

WHAT: Based on true events, Decoding Annie Parker follows a 15-year war waged on both scientific and emotional fronts by a pair of women demonstrating extreme bravery under pressure. Annie Parker (Samantha Morton), who lost her mother and sister to breast cancer is diagnosed with the disease, displaying a force of spirit that belies the odds. Elsewhere, geneticist Mary-Claire King (Helen Hunt) is researching the idea of an undiscovered link between DNA and cancer, a process that finds her scrambling for both funding and the support of her disbelieving colleagues.

WHO:   Atossa Genetics, Inc., The Breast Health Company™, is sponsoring two screenings of the new film Decoding Annie Parker at the Seattle International Film Festival on June 6 and 8, 2013. The company is offering free tickets to members of the media who wish to attend.

WHERE:   The Seattle International Film Festival's showing of Decoding Annie Parker will be at the Egyptian Theater, 801 E. Pine Street in Seattle, WA. The showing on June 6 th is at 7:00 PM PDT and the showing on June 8 th is at 1:30 PM PDT.

WHY : Seattle-based Atossa Genetics is focused on preventing breast cancer through the commercialization of patented diagnostic medical devices and patented laboratory developed tests (LDT) that can detect precursors to breast cancer up to eight years before mammography, and through research and development that will permit it to commercialize treatments for pre-cancerous lesions. The company has developed the patented ForeCYTE Breast Health Test, a risk assessment test for women ages 18 to 73 akin to the Pap Smear.

For additional information, please visit www.atossagenetics.com . You can also view a video about the ForeCYTE test here: https://vimeo.com/62365818

HOW:   Dr. Steven Quay, Chairman, CEO & President of Atossa Genetics, is available to discuss the company and its sponsorship of the film. 

CONTACT:   For tickets, please contact Cami Mahan of Atossa Genetics at 1-800-351-3902 or cami.mahan@atossagenetics.com . To Interview Dr. Quay, please contact Jules Abraham, 917-885-7378 or jabraham@jqapartners.com

Jules Abraham 917-885-7378 Email Contact

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Solis Agrosciences Gains Series A Funding to Drive Growth Forward

Updated Category News Views 272

Solis Agrosciences Gains Series A Funding to Drive Growth Forward Solis Agrosciences, a prominent name in the Agtech sector, has announced a significant milestone in its journey of innovation and growth. The company has successfully secured Series A funding from Cultivation Capital, an investment that promises to amplify its business operations and expand its array of...

Continue Reading
Blink Charging: Milestone Achievements and Future Outlook

Updated Category News Views 283

Update on Blink Charging and Its Stock Performance Blink Charging Co. (NASDAQ: BLNK) shares saw an upward trend recently, as the company proudly announced it surpassed 100,000 electric vehicle (EV) chargers sold, deployed, or contracted globally. This significant accomplishment highlights Blink's growth in the EV infrastructure sector. The company's success can be...

Continue Reading
Vanguard Unveils Innovative Active Equity ETF Range

Updated Category News Views 228

Vanguard Launches New Active Equity ETFs Vanguard has recently introduced three active equity ETFs aimed at enhancing investor portfolio options. The newly launched funds are the Vanguard Wellington U.S. Value Active ETF (VUSV), Vanguard Wellington U.S. Growth Active ETF (VUSG), and Vanguard Wellington Dividend Growth Active ETF (VDIG), each managed by the esteemed...

Continue Reading
New COVID-19 Vaccine by Pfizer and BioNTech Shows Promise

Updated Category News Views 244

Revamped Approach to COVID-19 Vaccination In a noteworthy advancement in the fight against the COVID-19 pandemic, Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) are set to introduce an LP.8.1-adapted monovalent COVID-19 vaccine following a positive recommendation from the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP)....

Continue Reading
Gold's Steady Climb Amid Geopolitical Tensions and Economic Shifts

Updated Category News Views 210

Gold Rises for Third Consecutive Session Gold (XAU/USD) has shown a steady increase of over 0.32%, reflecting a notable rise in safe-haven demand driven by global trade tensions. Investors remain concerned about the stability of global supply chains, making gold a popular choice during times of uncertainty. The yellow metal typically shines as a safe-haven asset when...

Continue Reading